Dr Edna Mutua
Contact information
Research groups
Edna Mutua
Honorary Visiting Research Fellow
Dr Mutua is a Social Scientist in the Health Systems Research Group. She joined the team mid-2021. She is the Principal Investigator of the AMR Governance and AMR funding landscapes studies, all implemented in Kenya and Vietnam. The AMR governance study assesses how health governance structures, functions, and processes affect antimicrobial resistance control while the AMR funding landscapes study focuses on AMR financing and its implications for AMR containment. She is a Co-Investigator in the CINAMR, HIGH-Q, and Beyond Survival projects implemented in Kenya. The Clinical Information Network-Antimicrobial Resistance (CINAMR) project’s objective is to pilot a “hub and spoke” approach for bacteraemia surveillance in LMIC settings that can be scaled and embedded in health systems, examining its feasibility, acceptability, and utility. The Learning to Harness Innovation in Global Health or Quality Care (HIGH – Q) project’s focus is on understanding how technological and human resource interventions can be designed and implemented successfully to enhance the quality of inpatient and post-discharge neonatal care. The Beyond Survival study seeks to understand how intrapartum childbirth care can contribute to positive health trajectories for both women and infants throughout the postpartum period.
Edna holds a PhD in Anthropology, and an MA in Gender and Development Studies from the University of Nairobi’s Department of Anthropology, Gender and African Studies. Her research interests are within the spheres of One Health, zoonotic diseases, antimicrobial resistance, and evaluation of health interventions in East Africa.
Podcast interview
Antimicrobial resistance surveillance and governance
In our global fight against antimicrobial resistance, KWTRP is piloting a surveillance project where hospital samples are transfered to high-capacity laboratories for analysis, to inform patient treatment and policy planning. Mitigating AMR is crucial as it can be costly in lives, hospital stays and livelihoods. An equitable AMR mitigation needs to balance gains and harms for just outcomes.